Expression and Clinical Significance of Decoy Receptor 3 in Acute-on-Chronic Liver Failure
Table 2
Comparison of clinical characteristics between survived and nonsurvived ACLF patients.
Non-survivals(n=38)
Survivals(n=38)
P value
Age(years)
50.24 ± 16.72
44.74 ± 13.25
0.116
Male (%)
28 (73.68%)
32 (84.21%)
0.266
TBIL(μmol/L)
376.71 ± 184.18
247.26 ± 98.30
<0.001
Albumin(g/L)
31.03 ± 4.56
30.26 ± 4.92
0.478
ALT (U/L)
202.50(85.00--856.25)
263.00(107.5--327.25)
0.901
AST(U/L)
201.00(128.25--571.75)
252.00(115.00--445.25)
0.954
γ-GT (U/L)
111.00(63.25--210.50)
139.00(88.25--213.00)
0.306
WBC(×109/L)
6.65(4.94--9.31)
6.09 (4.15--8.10)
0.187
N%
72.84 ± 8.96
66.77 ± 10.94
0.010
Platelet(×109/L)
88.00 (62.00--125.00)
121.00 (67.50--145.00)
0.245
Plasma ammonia (μmol/l)
64.85 ± 34.12
70.51 ± 27.81
0.444
Blood lactic acid
2.77 (2.20--3.50)
2.39 (1.87--3.08)
0.124
PT(s)
23.05(18.50--23.05)
19.8(16.78--23.95)
0.042
INR
2.00(1.60--2.44)
1.73(1.45--2.10)
0.041
CRP(mg/L)
19.15(10.06--27.64)
17.15(7.28--25.42)
0.421
PCT(ng/mL)
0.67 (0.38--1.24)
0.86 (0.53--1.84)
0.136
Serum creatinine(umol/L)
60.00(49.00--70.50)
63.00(35.00--172.00)
0.571
MELD score
21.37 ± 5.71
18.48 ± 5.11
0.022
MELD-Na score
19.38 ± 10.98
14.54 ± 8.92
0.039
Data in this table were obtained upon admission and expressed as the number of patients (percentage), mean ± standard deviation, or mean (interquartile range).
